Published in Medical Letter on the CDC and FDA, August 11th, 1997
They do recommend, however, that health care workers who sustain percutaneous or permucosal exposures to anti-HCV positive blood should be followed up actively. This includes immediate testing of the source patient for anti-HCV and, if positive, testing the exposed person at the time of injury for anti-HCV and after six months for anti-HCV and alanine amino transferase activity.
Guidance on the management of...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA